These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 6806770
1. Probable graft-vs-graft reaction in an infant after exchange transfusion and marrow transplantation. Lauer BA, Githens JH, Hayward AR, Conrad PD, Yanagihara RT, Tubergen DG. Pediatrics; 1982 Jul; 70(1):43-7. PubMed ID: 6806770 [Abstract] [Full Text] [Related]
2. [Bone marrow transplantation for aplastic anemia--initial results in 8 patients]. Hinterberger W, Gadner H, Höcker P, Hajek-Rosenmayr A, Graninger W, Hawlicek R, Stingl G, Bettelheim P, Korninger C, Neumann E, Niessner H, Schmidmeier W, Schroth B, Stellar C, Mayr W, Lechner K. Wien Klin Wochenschr; 1982 Oct 15; 94(19):504-9. PubMed ID: 6760559 [Abstract] [Full Text] [Related]
3. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor]. Watanabe H, Asai O, Tada N, Yano S, Katoh A, Katori M, Kobayashi T, Kuraishi Y, Hoshi Y, Itoh K, Aizawa S. Rinsho Ketsueki; 1997 Jan 15; 38(1):14-20. PubMed ID: 9028156 [Abstract] [Full Text] [Related]
6. Transplantation of incompatible bone marrow in infants with severe combined immunodeficiency disease. Park BY, Biggar WD, Good RA. Birth Defects Orig Artic Ser; 1975 Jan 15; 11(1):380-4. PubMed ID: 238680 [Abstract] [Full Text] [Related]
13. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M. Biol Blood Marrow Transplant; 1999 Sep 15; 5(3):133-43. PubMed ID: 10392959 [Abstract] [Full Text] [Related]
14. Relationship between donor-recipient blood group incompatibility and serum bilirubin after allogeneic bone marrow transplantation from HLA-identical siblings. Mehta J, Powles R, Horton C, Milan S, Singhal S, Treleaven J. Bone Marrow Transplant; 1995 Jun 15; 15(6):853-8. PubMed ID: 7581080 [Abstract] [Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May 15; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
16. [Pecularities of the rule of ABO transfusion compatibility in the neonatal period]. Sender A, Maigret P, Poulain M, Boeswillwald M, Lepage F. Ann Med Interne (Paris); 1971 Dec 15; 122(12):1263-6. PubMed ID: 5004914 [No Abstract] [Full Text] [Related]
17. Is the ABO incompatibility a risk factor in bone marrow transplantation? Rozman P, Kosir A, Bohinjec M. Transpl Immunol; 2005 Aug 15; 14(3-4):159-69. PubMed ID: 15982558 [Abstract] [Full Text] [Related]